RxDoctor Payments Data

Jenna Cooper, PA

Dermatology · Oxford, MSNPI 1427535079

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.4% of the total across 342 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 33.2% of the total.

$6,414in general payments, 2019–2025

Across 342 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sun Pharmaceutical Industries Inc.$970
  • Amgen$935
  • Johnson & Johnson$496
  • UCB, Inc.$452
  • Mallinckrodt Hospital Products Inc.$357
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$5,99293%
  • Education$4227%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,414 in reported general payments places this provider in the 55th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi

Medicare billing

Part B allowed, 2024
$604,596
Medicare patients
1,225
Services billed
10,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab35$132,623
Tacrolimus35$6,549
Fluorouracil72$4,684
Acitretin17$4,418
Imiquimod111$4,346
Clobetasol Propionate92$4,123
Tretinoin14$2,032
Triamcinolone Acetonide78$1,499
Doxycycline Hyclate96$1,181
Betamethasone Dipropionate21$466
Hydroxychloroquine Sulfate16$456
Terbinafine Hcl39$216
Azathioprine13$140
Gabapentin14$77
Mupirocin11$63

Paid to pharmacies, not to this prescriber.

Other dermatology in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →